For me, retirement planning means more than providing my clients with investment advice. It means helping them maintain the financial independence they’ve worked their whole lives to achieve. It means striving to ensure they have the means to pursue what’s most important to them. And it means understanding them as people with unique goals, values and circumstances that determine the strategies I develop on their behalf.
My consultative process begins with an in-depth discussion of your current finances and future objectives. We’ll address issues you might have overlooked that can have a significant impact on your ability to retire as planned. Finally, we’ll determine how we can help you adjust your investment strategy as necessary to accommodate changing conditions and meet any unforeseen expenses and income demands that may arise during retirement.
- Boys and Girls Club Advisory Board
- Connecticut Womens Council
- 401(k) Rollovers
- 529 Plans
- Alternative Investments
- Asset Management
- Business Succession Planning
- Corporate Retirement Plans
- Endowments and Foundations
- Exchange Traded Funds
- Executive Financial Services
- Family Consulting
- Insurance Services
- Life Insurance
- Long Term Care Insurance
- Professional Portfolio Management
- Qualified Plans
- Qualified Retirement Plans
- Retirement Planning
- Socially Responsible Investing
- Trust Services and Accounting
- Wealth Management
- Michigan State University
- Life and Health Insurance
- Variable Annuities
- Fixed Annuities
- Long Term Care
- Series 31 Managed Futures
- Series 7 General Securities
- Series 63 Uniform Securities Agent State Law
- Series 65 Uniform Investment Advisor Law
- Present: Morgan Stanley
Vice President Wealth Mangement
- 1994: Kidder Peabody
See September On the Markets from the Global Investment Committee featuring
• “Attitude Matters” Michael Wilson, chief investment officer of Morgan Stanley Wealth Management, says few investors believe the world can overcome the obstacles it faces. And this attitude, he adds, prevents them from seeing and acting on positive developments.
• “Say What? Biotech Is Cheaper Than Pharma?” Historically, US biotechnology stocks have traded at a big premium to big European and US pharmaceutical companies because of their much faster growth rate. But now, for a variety of reasons, biotech is on a par with big pharma or even cheaper. Adam Parker, chief US equity strategist for Morgan Stanley & Co., explains how this anomalous behavior came to be.
• "Higher Oil Prices and Reforms Give MLPs a Lift" Last year, midstream master limited partnerships faced a perfect storm of lower commodity prices, falling US hydrocarbon production and rising interest rates—and the results were brutal. Now, attractive valuation, higher energy prices and industry reforms give MLPs a brighter outlook, writes Vijay Chandar, market strategist for Morgan Stanley Wealth Management.
• Plus, look for more on equities, fixed income and a Q&A with Morgan Stanley Investment Management’s Ruchir Sharma about the changing nature of the emerging markets.
You can access your investment accounts by clicking on Log In To your portfolio.
Check the background of our Firm and Investment Professionals on FINRA's BrokerCheck.
Securities Agent: CA, CO, CT, DC, FL, IL, MA, MD, MI, NC, NH, NJ, NY, OH, PA, RI, VA, VT; General Securities Representative; Investment Advisor Representative; Managed Futures
On the Markets - Flipbook